from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2589/gabT

LFCtreatmentdescriptionclass of inhibitor

-0.621

Amikacinug/mL Amikacintranslation

-0.655

Cap5-10ug/mL Capreomycintranslation

-0.933

Rox10-50 ug/mL Roxithromycintranslation

-0.029

SM2-5 ug/mL Streptomycintranslation

-1.166

Tet5-10 ug/mL Tetracyclinetranslation

-0.890

Rif0.2-5ug/mL Rifampicintranscription

-0.520

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.775

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.647

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.015

CPZ10-50 ug/mL Chlorpromazinerespiration

0.918

Clofazimine10-13 ug/mL Clofaziminerespiration

0.483

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.877

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.919

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.217

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.555

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.492

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.638

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.131

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.093

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.948

KCN5-20 ug/mL Potassium cyaniderespiration

1.132

NaN30.2-2 mM Sodium aziderespiration

0.022

Nigericin50 uM Nigericinrespiration

-0.331

TRC10-150 ug/mL Triclosanrespiration

-0.446

TRZ10-25 ug/mL Thioridazinerespiration

0.336

Valinomycin0.5-10 uM Valinomycinrespiration

0.804

ZnSO42 mM ZnSO4respiration

0.114

menadione6-10 ug/mL Menadionerespiration

0.352

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.338

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.412

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.053

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.261

NRP_1Non-replicating persistence stage 1dosRassociated

0.109

Amp0.2mg/mL AmpicillincellWall

-0.174

Cephalexin20-100 ug/mL CephalexincellWall

-0.310

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.235

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.079

EMB10-20 ug/mL EthambutolcellWall

0.311

Eta12-40 ug/mL EthionamidecellWall

0.535

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.014

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.173

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.195

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.904

BZA0.12 mg/mL BenzamidearomaticAmides

-0.733

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.017

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.483

H2O24 mM hydrogen peroxideDNAdamaging

0.196

Levo10 ug/mL LevofloxacinDNAdamaging

-0.649

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

3.939

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.011

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.297

UVUV-irradiationDNAdamaging

0.526

ARP41-4 ug/mL Antitubercular compound ARP4?

0.110

Antimycin12.5-50 ug/mL Antimycin A?

0.107

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.090

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.618

PA_2110-50 ug/mL Antitubercular compound PA-21?

3.249

PA8240.2-2 ug/mL PA-824?

1.322

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.412

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.296

Verapamil50 uM Verapamil?

-0.065

mercaptoethanol2 mM 2-Mercaptoethanol?

0.211

methoxatin10-20 ug/mL Methoxatin?